ONCY:NASDAQ, Oncolytics Biotech Inc.

ONCY stock overview

Oncolytics Biotech Inc. (ONCY:NASDAQ) closed at $0.508 on October 21, 2026, up 1.95% on the day. The stock trades 61.5% below its 52-week high of $1.32 and 15.5% above its 52-week low of $0.440. Over the past year, it lost 57.7%. Oncolytics Biotech Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$0.508
Day change
+1.95%
Volume
159,211
Average volume
1,058,782
Market cap
66M+
52-week range
$0.440 – $1.32
50-day average
$0.724
200-day average
$0.884

Price action over the past year

In 252 trading sessions since October 20, 2025, ONCY closed higher on 93 days (37%). Its best day was February 13, 2026 (+27.71%) and its worst was October 12, 2026 (-16.07%). The stock moved 10% or more in a single session 16 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

ONCY news

About Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer that have not been successfully treated with conventional therapeutics.

Similar stocks

Find more stocks like ONCY with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.